Is ERAS Worth Buying in 2026?

Erasca, Inc. Common Stock

STOCK PHARMACEUTICAL PREPARATIONS Updated 2026-05-03

Here’s whether Erasca, Inc. Common Stock (ERAS) is worth buying in 2026 — based on weekly-updated price trend, RSI momentum, and return vs. the S&P 500. Our current read: Bullish.

🟢
Bullish

Positives: trading above the 200-day MA (long-term uptrend intact); 50-day MA is rising (+6.38% over 10 days); RSI 36 — healthy momentum range; strong 1-year return of +573.1%; rising volume confirms the move (1.70x 30d avg). Concerns: below the 50-day MA (medium-term momentum negative); 3-month momentum negative (-5.5%). Currently 58.7% off its 52-week high. Score: +4/7.

Ready to act on this? 📈 Trade on Webull

ERAS is holding above its long-term 200-day MA ($6.82) but has slipped below the 50-day MA ($15.69), pointing to short-term weakness in an otherwise intact trend. An RSI of 36.5 sits in the neutral zone — momentum is neither stretched nor exhausted. The 1-year return of +573.1% compares to +22.9% for SPY (beat the market by 550.3%). The current 58.7% drawdown from the 52-week high reflects elevated risk for momentum-based strategies.

$10,000 invested 1 year ago → $67,315 today
vs. S&P 500 (SPY) — same period beat market by 550.3%

1-Year Price Chart

Daily candles
MA-50 MA-200 Up Down

Signal Check

Above 200-day MA ($6.82)
Above 50-day MA ($15.69)
RSI(14) neutral zone (30–70) — currently 36.5
Positive return (+573.1%)
!Within 10% of period high (−58.7%)
Period Range $10.03
$1.06 $24.28
RSI (14) 36.5
0 · OversoldOverbought · 100

Key Metrics

Price$10.03
Period Return+573.1%
Period High$24.28
Period Low$1.06
Drawdown−58.7%
MA-50$15.69
MA-200$6.82
RSI (14)36.5
Avg Volume (30d)9.0M
vs. SPYbeat by 544.1%
Return Rank#26 of 1246

Trade ERAS

📈 Trade on Webull 📊 Trade on moomoo 💹 Interactive Brokers